Biotech solutions
Risk Modelling for Biotech
Beryl Analytics has spent the better part of a decade building risk modelling systems for biotech research labs across New Zealand and Australia. We know which patterns generalise, which break, and how to ship value in weeks rather than quarters.
Why biotech teams choose Beryl Analytics for risk modelling
- Decision-first scoping. Before we touch a model, we name the decision it will change, the owner, and the dollar metric. risk modelling that can't be tied back to one of those doesn't get built.
- Engineered observability. Every model ships with input drift detection, output distribution monitoring, and an alerting playbook. biotech research labs get systems that age gracefully.
- Boring tech where it matters. We default to the simplest model that meets the bar — gradient-boosted trees beat transformers far more often than vendors will admit.
- Pair-built, not handed over. Your engineers sit in every working session. They commit code. By go-live, the system is genuinely theirs.
- Honest post-mortems. Every engagement ends with a written read of what worked, what didn't, and what we'd tell biotech research labs to do next without us.
How we deliver risk modelling engagements
- 01
Discovery sprint (week 1)
Two days on-site with your operators to map the workflow, half a day with leadership to align on the dollar metric, and an afternoon writing the scope memo we'll work to.
- 02
Spike the riskiest assumption (weeks 2-3)
Before committing to the build, we attack the assumption most likely to kill the project — usually data availability or operator adoption. A negative result here saves months.
- 03
Build, in public (weeks 4-8)
Daily commits to a shared repo your engineers can read. Weekly demo to the operator group. Nothing is built in private.
- 04
Production cutover (weeks 9-10)
A planned cutover with a rollback plan, monitoring, and a human in the loop for the first fortnight. We don't walk away from cold launches.
Frequently asked questions about Risk Modelling for Biotech
How long does a typical Risk Modelling engagement take for a biotech business?
Most risk modelling projects for biotech research labs land a working production slice within 4-6 weeks, then harden and expand over the following 8-12 weeks. Larger biotech programmes that touch multiple business units take 4-6 months end-to-end.
What data do you need to start a Risk Modelling project in biotech?
Minimum viable inputs are 12-18 months of historical transactional or operational data, basic entity reference tables, and access to the systems that will consume the output. We can work with messy data — cleaning is part of the engagement.
Can Beryl Analytics integrate risk modelling with our existing biotech research labs systems?
Yes. We're tool-agnostic and have integrated with Snowflake, BigQuery, Databricks, Salesforce, SAP, Oracle, custom in-house platforms, and dozens of biotech-specific systems. Insights surface inside the tools your operators already use.
How do you measure success on a Risk Modelling engagement?
Before we model anything, we agree the business decision the output will change and the dollar metric we're targeting — revenue lifted, cost avoided, or risk reduced. Risk Modelling engagements in biotech typically return 4-12x within the first year.
Do you work with biotech businesses outside major NZ and AU cities?
Yes. We deliver remotely across New Zealand and Australia and visit on-site for discovery, key workshops, and go-live. Distance is not a blocker — many of our highest-impact risk modelling engagements have been with regional biotech research labs.